ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global PECAM-1 Antibody Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-15V7793
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global PECAM 1 Antibody Market Insights Forecast to 2028
BUY CHAPTERS

Global PECAM-1 Antibody Market Research Report 2025

Code: QYRE-Auto-15V7793
Report
July 2025
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Thermo Fisher
MilliporeSigma
Abcam
BioLegend
Novus Biologicals
Dianova
Santa Cruz Biotechnology
Proteintech Group
R&D Systems
Miltenyi Biotec
Bio Rad
LifeSpan BioSciences
Abnova
OriGene
SICGEN
YO Proteins
Enzo Life Sciences
Boster
Abeomics
Rockland Immunochemicals
Bon Opus Biosciences
Creative BioMart
US Biological

PECAM-1 Antibody Market

The global market for PECAM-1 Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for PECAM-1 Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for PECAM-1 Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of PECAM-1 Antibody include Thermo Fisher, MilliporeSigma, Abcam, BioLegend, Novus Biologicals, Dianova, Santa Cruz Biotechnology, Proteintech Group, R&D Systems, Miltenyi Biotec, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for PECAM-1 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PECAM-1 Antibody.
The PECAM-1 Antibody market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global PECAM-1 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PECAM-1 Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of PECAM-1 Antibody Market Report

Report Metric Details
Report Name PECAM-1 Antibody Market
Segment by Type
  • Mouse
  • Rabbit
  • Others
Segment by Application
  • Laboratory
  • Hospital
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Thermo Fisher, MilliporeSigma, Abcam, BioLegend, Novus Biologicals, Dianova, Santa Cruz Biotechnology, Proteintech Group, R&D Systems, Miltenyi Biotec, Bio-Rad, LifeSpan Biosciences, Abnova, OriGene, SICGEN, YO Proteins, Enzo Life Sciences, Boster, Abeomics, Rockland Immunochemicals, Bon Opus Biosciences, Creative Biomart, US Biological
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of PECAM-1 Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of PECAM-1 Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the PECAM-1 Antibody Market report?

Ans: The main players in the PECAM-1 Antibody Market are Thermo Fisher, MilliporeSigma, Abcam, BioLegend, Novus Biologicals, Dianova, Santa Cruz Biotechnology, Proteintech Group, R&D Systems, Miltenyi Biotec, Bio-Rad, LifeSpan Biosciences, Abnova, OriGene, SICGEN, YO Proteins, Enzo Life Sciences, Boster, Abeomics, Rockland Immunochemicals, Bon Opus Biosciences, Creative Biomart, US Biological

What are the Application segmentation covered in the PECAM-1 Antibody Market report?

Ans: The Applications covered in the PECAM-1 Antibody Market report are Laboratory, Hospital, Others

What are the Type segmentation covered in the PECAM-1 Antibody Market report?

Ans: The Types covered in the PECAM-1 Antibody Market report are Mouse, Rabbit, Others

1 PECAM-1 Antibody Market Overview
1.1 Product Definition
1.2 PECAM-1 Antibody by Type
1.2.1 Global PECAM-1 Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 Mouse
1.2.3 Rabbit
1.2.4 Others
1.3 PECAM-1 Antibody by Application
1.3.1 Global PECAM-1 Antibody Market Value by Application (2024 VS 2031)
1.3.2 Laboratory
1.3.3 Hospital
1.3.4 Others
1.4 Global PECAM-1 Antibody Market Size Estimates and Forecasts
1.4.1 Global PECAM-1 Antibody Revenue 2020-2031
1.4.2 Global PECAM-1 Antibody Sales 2020-2031
1.4.3 Global PECAM-1 Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 PECAM-1 Antibody Market Competition by Manufacturers
2.1 Global PECAM-1 Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global PECAM-1 Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global PECAM-1 Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of PECAM-1 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of PECAM-1 Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PECAM-1 Antibody, Product Type & Application
2.7 Global Key Manufacturers of PECAM-1 Antibody, Date of Enter into This Industry
2.8 Global PECAM-1 Antibody Market Competitive Situation and Trends
2.8.1 Global PECAM-1 Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest PECAM-1 Antibody Players Market Share by Revenue
2.8.3 Global PECAM-1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global PECAM-1 Antibody Market Scenario by Region
3.1 Global PECAM-1 Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global PECAM-1 Antibody Sales by Region: 2020-2031
3.2.1 Global PECAM-1 Antibody Sales by Region: 2020-2025
3.2.2 Global PECAM-1 Antibody Sales by Region: 2026-2031
3.3 Global PECAM-1 Antibody Revenue by Region: 2020-2031
3.3.1 Global PECAM-1 Antibody Revenue by Region: 2020-2025
3.3.2 Global PECAM-1 Antibody Revenue by Region: 2026-2031
3.4 North America PECAM-1 Antibody Market Facts & Figures by Country
3.4.1 North America PECAM-1 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America PECAM-1 Antibody Sales by Country (2020-2031)
3.4.3 North America PECAM-1 Antibody Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe PECAM-1 Antibody Market Facts & Figures by Country
3.5.1 Europe PECAM-1 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe PECAM-1 Antibody Sales by Country (2020-2031)
3.5.3 Europe PECAM-1 Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PECAM-1 Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific PECAM-1 Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific PECAM-1 Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific PECAM-1 Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America PECAM-1 Antibody Market Facts & Figures by Country
3.7.1 Latin America PECAM-1 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America PECAM-1 Antibody Sales by Country (2020-2031)
3.7.3 Latin America PECAM-1 Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa PECAM-1 Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa PECAM-1 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa PECAM-1 Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa PECAM-1 Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global PECAM-1 Antibody Sales by Type (2020-2031)
4.1.1 Global PECAM-1 Antibody Sales by Type (2020-2025)
4.1.2 Global PECAM-1 Antibody Sales by Type (2026-2031)
4.1.3 Global PECAM-1 Antibody Sales Market Share by Type (2020-2031)
4.2 Global PECAM-1 Antibody Revenue by Type (2020-2031)
4.2.1 Global PECAM-1 Antibody Revenue by Type (2020-2025)
4.2.2 Global PECAM-1 Antibody Revenue by Type (2026-2031)
4.2.3 Global PECAM-1 Antibody Revenue Market Share by Type (2020-2031)
4.3 Global PECAM-1 Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global PECAM-1 Antibody Sales by Application (2020-2031)
5.1.1 Global PECAM-1 Antibody Sales by Application (2020-2025)
5.1.2 Global PECAM-1 Antibody Sales by Application (2026-2031)
5.1.3 Global PECAM-1 Antibody Sales Market Share by Application (2020-2031)
5.2 Global PECAM-1 Antibody Revenue by Application (2020-2031)
5.2.1 Global PECAM-1 Antibody Revenue by Application (2020-2025)
5.2.2 Global PECAM-1 Antibody Revenue by Application (2026-2031)
5.2.3 Global PECAM-1 Antibody Revenue Market Share by Application (2020-2031)
5.3 Global PECAM-1 Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Thermo Fisher
6.1.1 Thermo Fisher Company Information
6.1.2 Thermo Fisher Description and Business Overview
6.1.3 Thermo Fisher PECAM-1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Thermo Fisher PECAM-1 Antibody Product Portfolio
6.1.5 Thermo Fisher Recent Developments/Updates
6.2 MilliporeSigma
6.2.1 MilliporeSigma Company Information
6.2.2 MilliporeSigma Description and Business Overview
6.2.3 MilliporeSigma PECAM-1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 MilliporeSigma PECAM-1 Antibody Product Portfolio
6.2.5 MilliporeSigma Recent Developments/Updates
6.3 Abcam
6.3.1 Abcam Company Information
6.3.2 Abcam Description and Business Overview
6.3.3 Abcam PECAM-1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Abcam PECAM-1 Antibody Product Portfolio
6.3.5 Abcam Recent Developments/Updates
6.4 BioLegend
6.4.1 BioLegend Company Information
6.4.2 BioLegend Description and Business Overview
6.4.3 BioLegend PECAM-1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 BioLegend PECAM-1 Antibody Product Portfolio
6.4.5 BioLegend Recent Developments/Updates
6.5 Novus Biologicals
6.5.1 Novus Biologicals Company Information
6.5.2 Novus Biologicals Description and Business Overview
6.5.3 Novus Biologicals PECAM-1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novus Biologicals PECAM-1 Antibody Product Portfolio
6.5.5 Novus Biologicals Recent Developments/Updates
6.6 Dianova
6.6.1 Dianova Company Information
6.6.2 Dianova Description and Business Overview
6.6.3 Dianova PECAM-1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Dianova PECAM-1 Antibody Product Portfolio
6.6.5 Dianova Recent Developments/Updates
6.7 Santa Cruz Biotechnology
6.7.1 Santa Cruz Biotechnology Company Information
6.7.2 Santa Cruz Biotechnology Description and Business Overview
6.7.3 Santa Cruz Biotechnology PECAM-1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Santa Cruz Biotechnology PECAM-1 Antibody Product Portfolio
6.7.5 Santa Cruz Biotechnology Recent Developments/Updates
6.8 Proteintech Group
6.8.1 Proteintech Group Company Information
6.8.2 Proteintech Group Description and Business Overview
6.8.3 Proteintech Group PECAM-1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Proteintech Group PECAM-1 Antibody Product Portfolio
6.8.5 Proteintech Group Recent Developments/Updates
6.9 R&D Systems
6.9.1 R&D Systems Company Information
6.9.2 R&D Systems Description and Business Overview
6.9.3 R&D Systems PECAM-1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.9.4 R&D Systems PECAM-1 Antibody Product Portfolio
6.9.5 R&D Systems Recent Developments/Updates
6.10 Miltenyi Biotec
6.10.1 Miltenyi Biotec Company Information
6.10.2 Miltenyi Biotec Description and Business Overview
6.10.3 Miltenyi Biotec PECAM-1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Miltenyi Biotec PECAM-1 Antibody Product Portfolio
6.10.5 Miltenyi Biotec Recent Developments/Updates
6.11 Bio-Rad
6.11.1 Bio-Rad Company Information
6.11.2 Bio-Rad Description and Business Overview
6.11.3 Bio-Rad PECAM-1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Bio-Rad PECAM-1 Antibody Product Portfolio
6.11.5 Bio-Rad Recent Developments/Updates
6.12 LifeSpan Biosciences
6.12.1 LifeSpan Biosciences Company Information
6.12.2 LifeSpan Biosciences Description and Business Overview
6.12.3 LifeSpan Biosciences PECAM-1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.12.4 LifeSpan Biosciences PECAM-1 Antibody Product Portfolio
6.12.5 LifeSpan Biosciences Recent Developments/Updates
6.13 Abnova
6.13.1 Abnova Company Information
6.13.2 Abnova Description and Business Overview
6.13.3 Abnova PECAM-1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Abnova PECAM-1 Antibody Product Portfolio
6.13.5 Abnova Recent Developments/Updates
6.14 OriGene
6.14.1 OriGene Company Information
6.14.2 OriGene Description and Business Overview
6.14.3 OriGene PECAM-1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.14.4 OriGene PECAM-1 Antibody Product Portfolio
6.14.5 OriGene Recent Developments/Updates
6.15 SICGEN
6.15.1 SICGEN Company Information
6.15.2 SICGEN Description and Business Overview
6.15.3 SICGEN PECAM-1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.15.4 SICGEN PECAM-1 Antibody Product Portfolio
6.15.5 SICGEN Recent Developments/Updates
6.16 YO Proteins
6.16.1 YO Proteins Company Information
6.16.2 YO Proteins Description and Business Overview
6.16.3 YO Proteins PECAM-1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.16.4 YO Proteins PECAM-1 Antibody Product Portfolio
6.16.5 YO Proteins Recent Developments/Updates
6.17 Enzo Life Sciences
6.17.1 Enzo Life Sciences Company Information
6.17.2 Enzo Life Sciences Description and Business Overview
6.17.3 Enzo Life Sciences PECAM-1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Enzo Life Sciences PECAM-1 Antibody Product Portfolio
6.17.5 Enzo Life Sciences Recent Developments/Updates
6.18 Boster
6.18.1 Boster Company Information
6.18.2 Boster Description and Business Overview
6.18.3 Boster PECAM-1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Boster PECAM-1 Antibody Product Portfolio
6.18.5 Boster Recent Developments/Updates
6.19 Abeomics
6.19.1 Abeomics Company Information
6.19.2 Abeomics Description and Business Overview
6.19.3 Abeomics PECAM-1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Abeomics PECAM-1 Antibody Product Portfolio
6.19.5 Abeomics Recent Developments/Updates
6.20 Rockland Immunochemicals
6.20.1 Rockland Immunochemicals Company Information
6.20.2 Rockland Immunochemicals Description and Business Overview
6.20.3 Rockland Immunochemicals PECAM-1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Rockland Immunochemicals PECAM-1 Antibody Product Portfolio
6.20.5 Rockland Immunochemicals Recent Developments/Updates
6.21 Bon Opus Biosciences
6.21.1 Bon Opus Biosciences Company Information
6.21.2 Bon Opus Biosciences Description and Business Overview
6.21.3 Bon Opus Biosciences PECAM-1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Bon Opus Biosciences PECAM-1 Antibody Product Portfolio
6.21.5 Bon Opus Biosciences Recent Developments/Updates
6.22 Creative Biomart
6.22.1 Creative Biomart Company Information
6.22.2 Creative Biomart Description and Business Overview
6.22.3 Creative Biomart PECAM-1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Creative Biomart PECAM-1 Antibody Product Portfolio
6.22.5 Creative Biomart Recent Developments/Updates
6.23 US Biological
6.23.1 US Biological Company Information
6.23.2 US Biological Description and Business Overview
6.23.3 US Biological PECAM-1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.23.4 US Biological PECAM-1 Antibody Product Portfolio
6.23.5 US Biological Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PECAM-1 Antibody Industry Chain Analysis
7.2 PECAM-1 Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PECAM-1 Antibody Production Mode & Process Analysis
7.4 PECAM-1 Antibody Sales and Marketing
7.4.1 PECAM-1 Antibody Sales Channels
7.4.2 PECAM-1 Antibody Distributors
7.5 PECAM-1 Antibody Customer Analysis
8 PECAM-1 Antibody Market Dynamics
8.1 PECAM-1 Antibody Industry Trends
8.2 PECAM-1 Antibody Market Drivers
8.3 PECAM-1 Antibody Market Challenges
8.4 PECAM-1 Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Thermo Fisher
MilliporeSigma
Abcam
BioLegend
Novus Biologicals
Dianova
Santa Cruz Biotechnology
Proteintech Group
R&D Systems
Miltenyi Biotec
Bio Rad
LifeSpan BioSciences
Abnova
OriGene
SICGEN
YO Proteins
Enzo Life Sciences
Boster
Abeomics
Rockland Immunochemicals
Bon Opus Biosciences
Creative BioMart
US Biological
List of Tables
 Table 1. Global PECAM-1 Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global PECAM-1 Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global PECAM-1 Antibody Market Competitive Situation by Manufacturers in 2024
 Table 4. Global PECAM-1 Antibody Sales (Kg) of Key Manufacturers (2020-2025)
 Table 5. Global PECAM-1 Antibody Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global PECAM-1 Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global PECAM-1 Antibody Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market PECAM-1 Antibody Average Price (USD/g) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of PECAM-1 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of PECAM-1 Antibody, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of PECAM-1 Antibody, Product Type & Application
 Table 12. Global Key Manufacturers of PECAM-1 Antibody, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global PECAM-1 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PECAM-1 Antibody as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global PECAM-1 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global PECAM-1 Antibody Sales by Region (2020-2025) & (Kg)
 Table 18. Global PECAM-1 Antibody Sales Market Share by Region (2020-2025)
 Table 19. Global PECAM-1 Antibody Sales by Region (2026-2031) & (Kg)
 Table 20. Global PECAM-1 Antibody Sales Market Share by Region (2026-2031)
 Table 21. Global PECAM-1 Antibody Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global PECAM-1 Antibody Revenue Market Share by Region (2020-2025)
 Table 23. Global PECAM-1 Antibody Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global PECAM-1 Antibody Revenue Market Share by Region (2026-2031)
 Table 25. North America PECAM-1 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America PECAM-1 Antibody Sales by Country (2020-2025) & (Kg)
 Table 27. North America PECAM-1 Antibody Sales by Country (2026-2031) & (Kg)
 Table 28. North America PECAM-1 Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America PECAM-1 Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe PECAM-1 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe PECAM-1 Antibody Sales by Country (2020-2025) & (Kg)
 Table 32. Europe PECAM-1 Antibody Sales by Country (2026-2031) & (Kg)
 Table 33. Europe PECAM-1 Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe PECAM-1 Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific PECAM-1 Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific PECAM-1 Antibody Sales by Region (2020-2025) & (Kg)
 Table 37. Asia Pacific PECAM-1 Antibody Sales by Region (2026-2031) & (Kg)
 Table 38. Asia Pacific PECAM-1 Antibody Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific PECAM-1 Antibody Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America PECAM-1 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America PECAM-1 Antibody Sales by Country (2020-2025) & (Kg)
 Table 42. Latin America PECAM-1 Antibody Sales by Country (2026-2031) & (Kg)
 Table 43. Latin America PECAM-1 Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America PECAM-1 Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa PECAM-1 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa PECAM-1 Antibody Sales by Country (2020-2025) & (Kg)
 Table 47. Middle East and Africa PECAM-1 Antibody Sales by Country (2026-2031) & (Kg)
 Table 48. Middle East and Africa PECAM-1 Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa PECAM-1 Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global PECAM-1 Antibody Sales (Kg) by Type (2020-2025)
 Table 51. Global PECAM-1 Antibody Sales (Kg) by Type (2026-2031)
 Table 52. Global PECAM-1 Antibody Sales Market Share by Type (2020-2025)
 Table 53. Global PECAM-1 Antibody Sales Market Share by Type (2026-2031)
 Table 54. Global PECAM-1 Antibody Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global PECAM-1 Antibody Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global PECAM-1 Antibody Revenue Market Share by Type (2020-2025)
 Table 57. Global PECAM-1 Antibody Revenue Market Share by Type (2026-2031)
 Table 58. Global PECAM-1 Antibody Price (USD/g) by Type (2020-2025)
 Table 59. Global PECAM-1 Antibody Price (USD/g) by Type (2026-2031)
 Table 60. Global PECAM-1 Antibody Sales (Kg) by Application (2020-2025)
 Table 61. Global PECAM-1 Antibody Sales (Kg) by Application (2026-2031)
 Table 62. Global PECAM-1 Antibody Sales Market Share by Application (2020-2025)
 Table 63. Global PECAM-1 Antibody Sales Market Share by Application (2026-2031)
 Table 64. Global PECAM-1 Antibody Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global PECAM-1 Antibody Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global PECAM-1 Antibody Revenue Market Share by Application (2020-2025)
 Table 67. Global PECAM-1 Antibody Revenue Market Share by Application (2026-2031)
 Table 68. Global PECAM-1 Antibody Price (USD/g) by Application (2020-2025)
 Table 69. Global PECAM-1 Antibody Price (USD/g) by Application (2026-2031)
 Table 70. Thermo Fisher Company Information
 Table 71. Thermo Fisher Description and Business Overview
 Table 72. Thermo Fisher PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 73. Thermo Fisher PECAM-1 Antibody Product
 Table 74. Thermo Fisher Recent Developments/Updates
 Table 75. MilliporeSigma Company Information
 Table 76. MilliporeSigma Description and Business Overview
 Table 77. MilliporeSigma PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 78. MilliporeSigma PECAM-1 Antibody Product
 Table 79. MilliporeSigma Recent Developments/Updates
 Table 80. Abcam Company Information
 Table 81. Abcam Description and Business Overview
 Table 82. Abcam PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 83. Abcam PECAM-1 Antibody Product
 Table 84. Abcam Recent Developments/Updates
 Table 85. BioLegend Company Information
 Table 86. BioLegend Description and Business Overview
 Table 87. BioLegend PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 88. BioLegend PECAM-1 Antibody Product
 Table 89. BioLegend Recent Developments/Updates
 Table 90. Novus Biologicals Company Information
 Table 91. Novus Biologicals Description and Business Overview
 Table 92. Novus Biologicals PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 93. Novus Biologicals PECAM-1 Antibody Product
 Table 94. Novus Biologicals Recent Developments/Updates
 Table 95. Dianova Company Information
 Table 96. Dianova Description and Business Overview
 Table 97. Dianova PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 98. Dianova PECAM-1 Antibody Product
 Table 99. Dianova Recent Developments/Updates
 Table 100. Santa Cruz Biotechnology Company Information
 Table 101. Santa Cruz Biotechnology Description and Business Overview
 Table 102. Santa Cruz Biotechnology PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 103. Santa Cruz Biotechnology PECAM-1 Antibody Product
 Table 104. Santa Cruz Biotechnology Recent Developments/Updates
 Table 105. Proteintech Group Company Information
 Table 106. Proteintech Group Description and Business Overview
 Table 107. Proteintech Group PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 108. Proteintech Group PECAM-1 Antibody Product
 Table 109. Proteintech Group Recent Developments/Updates
 Table 110. R&D Systems Company Information
 Table 111. R&D Systems Description and Business Overview
 Table 112. R&D Systems PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 113. R&D Systems PECAM-1 Antibody Product
 Table 114. R&D Systems Recent Developments/Updates
 Table 115. Miltenyi Biotec Company Information
 Table 116. Miltenyi Biotec Description and Business Overview
 Table 117. Miltenyi Biotec PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 118. Miltenyi Biotec PECAM-1 Antibody Product
 Table 119. Miltenyi Biotec Recent Developments/Updates
 Table 120. Bio-Rad Company Information
 Table 121. Bio-Rad Description and Business Overview
 Table 122. Bio-Rad PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 123. Bio-Rad PECAM-1 Antibody Product
 Table 124. Bio-Rad Recent Developments/Updates
 Table 125. LifeSpan Biosciences Company Information
 Table 126. LifeSpan Biosciences Description and Business Overview
 Table 127. LifeSpan Biosciences PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 128. LifeSpan Biosciences PECAM-1 Antibody Product
 Table 129. LifeSpan Biosciences Recent Developments/Updates
 Table 130. Abnova Company Information
 Table 131. Abnova Description and Business Overview
 Table 132. Abnova PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 133. Abnova PECAM-1 Antibody Product
 Table 134. Abnova Recent Developments/Updates
 Table 135. OriGene Company Information
 Table 136. OriGene Description and Business Overview
 Table 137. OriGene PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 138. OriGene PECAM-1 Antibody Product
 Table 139. OriGene Recent Developments/Updates
 Table 140. SICGEN Company Information
 Table 141. SICGEN Description and Business Overview
 Table 142. SICGEN PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 143. SICGEN PECAM-1 Antibody Product
 Table 144. SICGEN Recent Developments/Updates
 Table 145. YO Proteins Company Information
 Table 146. YO Proteins Description and Business Overview
 Table 147. YO Proteins PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 148. YO Proteins PECAM-1 Antibody Product
 Table 149. YO Proteins Recent Developments/Updates
 Table 150. Enzo Life Sciences Company Information
 Table 151. Enzo Life Sciences Description and Business Overview
 Table 152. Enzo Life Sciences PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 153. Enzo Life Sciences PECAM-1 Antibody Product
 Table 154. Enzo Life Sciences Recent Developments/Updates
 Table 155. Boster Company Information
 Table 156. Boster Description and Business Overview
 Table 157. Boster PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 158. Boster PECAM-1 Antibody Product
 Table 159. Boster Recent Developments/Updates
 Table 160. Abeomics Company Information
 Table 161. Abeomics Description and Business Overview
 Table 162. Abeomics PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 163. Abeomics PECAM-1 Antibody Product
 Table 164. Abeomics Recent Developments/Updates
 Table 165. Rockland Immunochemicals Company Information
 Table 166. Rockland Immunochemicals Description and Business Overview
 Table 167. Rockland Immunochemicals PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 168. Rockland Immunochemicals PECAM-1 Antibody Product
 Table 169. Rockland Immunochemicals Recent Developments/Updates
 Table 170. Bon Opus Biosciences Company Information
 Table 171. Bon Opus Biosciences Description and Business Overview
 Table 172. Bon Opus Biosciences PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 173. Bon Opus Biosciences PECAM-1 Antibody Product
 Table 174. Bon Opus Biosciences Recent Developments/Updates
 Table 175. Creative Biomart Company Information
 Table 176. Creative Biomart Description and Business Overview
 Table 177. Creative Biomart PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 178. Creative Biomart PECAM-1 Antibody Product
 Table 179. Creative Biomart Recent Developments/Updates
 Table 180. US Biological Company Information
 Table 181. US Biological Description and Business Overview
 Table 182. US Biological PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 183. US Biological PECAM-1 Antibody Product
 Table 184. US Biological Recent Developments/Updates
 Table 185. Key Raw Materials Lists
 Table 186. Raw Materials Key Suppliers Lists
 Table 187. PECAM-1 Antibody Distributors List
 Table 188. PECAM-1 Antibody Customers List
 Table 189. PECAM-1 Antibody Market Trends
 Table 190. PECAM-1 Antibody Market Drivers
 Table 191. PECAM-1 Antibody Market Challenges
 Table 192. PECAM-1 Antibody Market Restraints
 Table 193. Research Programs/Design for This Report
 Table 194. Key Data Information from Secondary Sources
 Table 195. Key Data Information from Primary Sources
 Table 196. Authors List of This Report


List of Figures
 Figure 1. Product Picture of PECAM-1 Antibody
 Figure 2. Global PECAM-1 Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global PECAM-1 Antibody Market Share by Type: 2024 & 2031
 Figure 4. Mouse Product Picture
 Figure 5. Rabbit Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global PECAM-1 Antibody Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global PECAM-1 Antibody Market Share by Application: 2024 & 2031
 Figure 9. Laboratory
 Figure 10. Hospital
 Figure 11. Others
 Figure 12. Global PECAM-1 Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global PECAM-1 Antibody Market Size (2020-2031) & (US$ Million)
 Figure 14. Global PECAM-1 Antibody Sales (2020-2031) & (Kg)
 Figure 15. Global PECAM-1 Antibody Average Price (USD/g) & (2020-2031)
 Figure 16. PECAM-1 Antibody Report Years Considered
 Figure 17. PECAM-1 Antibody Sales Share by Manufacturers in 2024
 Figure 18. Global PECAM-1 Antibody Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest PECAM-1 Antibody Players: Market Share by Revenue in PECAM-1 Antibody in 2024
 Figure 20. PECAM-1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global PECAM-1 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America PECAM-1 Antibody Sales Market Share by Country (2020-2031)
 Figure 23. North America PECAM-1 Antibody Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. PECAM-1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada PECAM-1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe PECAM-1 Antibody Sales Market Share by Country (2020-2031)
 Figure 27. Europe PECAM-1 Antibody Revenue Market Share by Country (2020-2031)
 Figure 28. Germany PECAM-1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France PECAM-1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. PECAM-1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy PECAM-1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia PECAM-1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific PECAM-1 Antibody Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific PECAM-1 Antibody Revenue Market Share by Region (2020-2031)
 Figure 35. China PECAM-1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan PECAM-1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea PECAM-1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India PECAM-1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia PECAM-1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan PECAM-1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia PECAM-1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand PECAM-1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia PECAM-1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines PECAM-1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America PECAM-1 Antibody Sales Market Share by Country (2020-2031)
 Figure 46. Latin America PECAM-1 Antibody Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico PECAM-1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil PECAM-1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina PECAM-1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa PECAM-1 Antibody Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa PECAM-1 Antibody Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey PECAM-1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia PECAM-1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE PECAM-1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of PECAM-1 Antibody by Type (2020-2031)
 Figure 56. Global Revenue Market Share of PECAM-1 Antibody by Type (2020-2031)
 Figure 57. Global PECAM-1 Antibody Price (USD/g) by Type (2020-2031)
 Figure 58. Global Sales Market Share of PECAM-1 Antibody by Application (2020-2031)
 Figure 59. Global Revenue Market Share of PECAM-1 Antibody by Application (2020-2031)
 Figure 60. Global PECAM-1 Antibody Price (USD/g) by Application (2020-2031)
 Figure 61. PECAM-1 Antibody Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global PECAM 1 Protein Market Research Report 2024
Global PECAM1 Assay Market Research Report 2024
Global PECAM1 ELISA Kit Market Research Report 2024
Global BCAM Antibody Market Research Report 2024
Global GFAP Antibody Market Research Report 2024
Global Pembrolizumab Market Research Report 2024
Global Erk1 Antibody Market Research Report 2024
Global JAG1 Antibody Market Research Report 2024
Global Antibody Array Market Research Report 2025
Global ALK 1 Antibody Market Research Report 2024
Global Antibodies Market Research Report 2024
Global PARP1 Antibody Market Research Report 2024
Global Escherichia Coli Antibody Market Research Report 2024
Global Antibody Microarrays Market Research Report 2025
Global Primary Antibody Market Research Report 2024
Global Epitope Tag Antibody Market Research Report 2024
Global EpCAM Antibody Market Research Report 2024
Global CAPG Antibody Market Research Report 2024
Global Antibody Chips Market Research Report 2025
Global EXT1 Antibody Market Research Report 2025

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions